Countries affected
Visit our COVID-19 microsite for the latest coronavirus news, analysis and updates GlobalData's latest Coronavirus Influencers…
Covid-19
Coronavirus
-
Global confirmed cases155,425,396
-
Global deaths3,246,843
-
Global death rate2.09%
-
Global recoveries104,333,818
-
Global recovery rate67.13%
-
Global confirmed cases155,425,396
-
Global deaths3,246,843
-
Global death rate2.09%
-
Global recoveries104,333,818
-
Global recovery rate67.13%
Coronavirus COVID-19 outbreakLatest news, information and updates
As the coronavirus spreads globally we track the confirmed cases, deaths, recoveries through this microsite, dedicated to Covid-19 updates. The microsite also provides insights into the international spread and social media reaction, alongside a coronavirus FAQ and all the latest news and information concerning the outbreak.
What you need to know
Suspected Cases
Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Follow the updates…
Social media tracker
Coronavirus Social Media Dashboard Pharmaceutical companies are in the spotlight as they race to develop…
Frequently asked questions
Answers to some of the most popular FAQs on coronavirus outbreak and COVID-19
Side-by-side comparison
Total cases vs total recovered patients vs total deaths.
Side-by-side comparison
COVID-19 is a global pandemic, with China accounting for a small share of cases
Coronavirus Blog
View MoreLatest on Coronavirus
View More
Health Canada approves Pfizer and BioNTech’s Covid-19 vaccine for adolescents
With Health Canada authorisation, the Pfizer and BioNTech vaccine became the first-of-its-kind indicated for this age group to receive approval in the country. Based on…
Novavax Covid-19 vaccine provides cross-protection against B.1.351 variant
The protein-based vaccine candidate NVX-CoV2373 is made from the genetic sequence of the first SARS-CoV-2 strain. It is adjuvanted with the company’s saponin-based Matrix-M to…
Pfizer’s Covid-19 vaccine sales boost revenue in Q1 2021
Pfizer has increased 2021 financial guidance for its Covid-19 vaccine candidate BNT162b2 after the product generated $3.5bn in global revenues during the first quarter (Q1)…
HDT Bio and Gennova dose healthy subjects in Covid-19 trial in India
HDT Bio and its development partner in India, Gennova Biopharmaceuticals, have started dosing healthy subjects with the Covid-19 vaccine in a Phase I/II trial in…
eFFECTOR and QBI to study anti-viral agent for Covid-19 treatment
eFFECTOR Therapeutics and Quantitative Biosciences Institute (QBI) at the University of California, San Francisco (UCSF), have announced a $5m cooperative agreement for a planned Phase…
Moderna to supply Covid-19 vaccine doses to Gavi
Moderna has entered an agreement with Gavi, the Vaccine Alliance, to deliver up to 500 million doses of its mRNA Covid-19 vaccine to help low-…
